Your browser is no longer supported. Please, upgrade your browser.
FOLD [NASD]
Amicus Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.15 Insider Own1.00% Shs Outstand259.16M Perf Week-9.45%
Market Cap5.86B Forward P/E- EPS next Y-0.78 Insider Trans-20.84% Shs Float234.07M Perf Month-12.71%
Income-295.20M PEG- EPS next Q-0.23 Inst Own- Short Float12.68% Perf Quarter19.56%
Sales245.60M P/S23.87 EPS this Y21.10% Inst Trans0.01% Short Ratio11.98 Perf Half Y43.18%
Book/sh1.24 P/B17.01 EPS next Y23.50% ROA-37.00% Target Price24.81 Perf Year127.51%
Cash/sh1.83 P/C11.51 EPS next 5Y-1.00% ROE-75.70% 52W Range6.25 - 25.39 Perf YTD-8.66%
Dividend- P/FCF- EPS past 5Y-9.90% ROI-55.10% 52W High-16.94% Beta1.39
Dividend %- Quick Ratio5.10 Sales past 5Y172.00% Gross Margin88.40% 52W Low237.44% ATR1.18
Employees584 Current Ratio5.20 Sales Q/Q38.10% Oper. Margin- RSI (14)41.36 Volatility6.28% 5.34%
OptionableYes Debt/Eq1.21 EPS Q/Q-1.80% Profit Margin- Rel Volume0.86 Prev Close20.22
ShortableYes LT Debt/Eq1.21 EarningsNov 05 BMO Payout- Avg Volume2.48M Price21.09
Recom2.10 SMA20-7.57% SMA50-7.25% SMA20029.27% Volume2,133,440 Change4.30%
Dec-28-20Resumed Cantor Fitzgerald Overweight $20 → $30
Dec-10-20Downgrade Citigroup Buy → Neutral $20 → $27
Nov-11-20Initiated Berenberg Hold
Jun-17-20Initiated BTIG Research Buy $19
Feb-04-20Resumed Cantor Fitzgerald Overweight $19 → $20
Nov-12-19Reiterated H.C. Wainwright Buy $18 → $20
Jun-17-19Initiated H.C. Wainwright Buy $18
Jun-05-19Reiterated Cantor Fitzgerald Overweight $20 → $19
Apr-05-19Initiated Janney Buy
Jan-30-19Initiated Cantor Fitzgerald Overweight $20
Oct-29-18Initiated Citigroup Neutral $12
Aug-17-18Downgrade Chardan Capital Markets Buy → Neutral $18 → $15
Oct-06-17Resumed Goldman Neutral
Sep-13-17Reiterated Chardan Capital Markets Buy $17.50 → $16.50
Aug-10-17Reiterated Chardan Capital Markets Buy $12.50 → $17.50
Jan-24-17Upgrade Robert W. Baird Neutral → Outperform $7 → $10
May-18-16Initiated BofA/Merrill Buy $10
Apr-14-16Initiated Robert W. Baird Neutral $9
Apr-12-16Reiterated Chardan Capital Markets Buy $10 → $15
Sep-16-15Downgrade Chardan Capital Markets Buy → Neutral $17
Jan-21-21 07:00AM  
Jan-18-21 02:37AM  
Jan-11-21 07:00AM  
Jan-05-21 07:00AM  
Dec-21-20 11:36AM  
Dec-18-20 02:00PM  
Dec-15-20 08:42AM  
Dec-13-20 03:16AM  
Dec-07-20 07:00AM  
Dec-05-20 11:32AM  
Dec-02-20 03:52PM  
07:00AM  
Dec-01-20 07:00AM  
Nov-23-20 07:00AM  
Nov-19-20 09:16AM  
Nov-07-20 09:29AM  
Nov-06-20 06:30PM  
10:52AM  
Nov-05-20 09:15AM  
07:00AM  
06:30AM  
Nov-02-20 07:00AM  
Oct-29-20 12:34PM  
Oct-26-20 07:02AM  
Oct-22-20 07:00AM  
Oct-18-20 08:31AM  
Oct-12-20 08:22AM  
07:00AM  
Sep-24-20 07:00AM  
Sep-15-20 09:07AM  
Sep-09-20 11:30AM  
Sep-04-20 06:37AM  
Sep-03-20 07:00AM  
Aug-10-20 07:01PM  
08:25AM  
07:27AM  
07:00AM  
Aug-04-20 07:00AM  
Aug-03-20 12:31PM  
Jul-31-20 07:42AM  
Jul-28-20 07:00AM  
Jul-17-20 08:04AM  
07:32AM  
Jul-12-20 08:16PM  
Jun-22-20 09:23AM  
Jun-08-20 03:38AM  
Jun-06-20 11:31AM  
Jun-04-20 07:00AM  
May-21-20 02:25PM  
May-19-20 09:47AM  
May-10-20 09:50AM  
May-09-20 01:31PM  
May-08-20 11:46AM  
07:00AM  
May-07-20 09:25AM  
07:00AM  
May-06-20 07:00AM  
May-05-20 07:00AM  
Apr-30-20 12:33PM  
Apr-24-20 07:00AM  
Apr-13-20 08:42AM  
Apr-01-20 11:30AM  
Mar-28-20 08:38PM  
Mar-24-20 10:00AM  
Mar-23-20 07:00AM  
Mar-05-20 07:00AM  
Mar-04-20 07:20AM  
Mar-03-20 02:20PM  
09:38AM  
Mar-02-20 08:25AM  
07:00AM  
Feb-26-20 07:00AM  
Feb-24-20 12:30PM  
Feb-19-20 07:00AM  
Feb-17-20 07:43AM  
Feb-07-20 07:00AM  
Jan-13-20 07:00AM  
Jan-10-20 11:43AM  
Jan-09-20 07:00AM  
Jan-08-20 10:04AM  
Jan-07-20 07:00AM  
Jan-06-20 06:32PM  
Jan-03-20 09:41AM  
Jan-02-20 08:04AM  
Dec-11-19 11:30AM  
Dec-05-19 10:53PM  
Dec-04-19 09:28AM  
Nov-20-19 10:09AM  
Nov-19-19 03:03PM  
Nov-18-19 09:24AM  
Nov-12-19 09:52AM  
09:33AM  
09:25AM  
Nov-11-19 08:15AM  
07:00AM  
Nov-08-19 12:47PM  
Nov-07-19 11:41AM  
11:15AM  
10:32AM  
Nov-05-19 11:50AM  
Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of therapies to treat a range of rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 3 (ATB200-03) clinical study of AT-GAA for Pompe disease. The company has collaboration and license agreements with Nationwide Children's Hospital and University of Pennsylvania. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Crowley John FChairman & CEOJan 20Sale21.5150,0001,075,325859,388Jan 20 06:14 PM
Crowley John FChairman & CEOJan 15Option Exercise6.4522,000141,900931,388Jan 20 06:14 PM
Crowley John FChairman & CEOJan 15Sale22.2422,000489,368909,388Jan 20 06:14 PM
Campbell Bradley LChief Operating OfficerJan 04Option Exercise6.4510,51467,815316,847Jan 05 07:40 PM
WHITMAN BURKE WDirectorJan 04Buy23.171,50034,75539,967Jan 05 07:31 PM
Campbell Bradley LChief Operating OfficerJan 04Sale22.1710,514233,125306,333Jan 05 07:40 PM
Crowley John FChairman & CEOJan 04Sale22.177,500166,305745,429Jan 05 08:07 PM
Quimi DaphneChief Financial OfficerDec 21Option Exercise2.945,00014,700249,344Dec 23 05:45 PM
Quimi DaphneChief Financial OfficerDec 21Sale24.095,000120,474244,344Dec 23 05:45 PM
Campbell Bradley LChief Operating OfficerDec 15Option Exercise5.4520,828113,597359,592Dec 17 04:31 PM
Quimi DaphneChief Financial OfficerDec 15Option Exercise3.2730,32199,222248,500Dec 17 04:32 PM
Crowley John FChairman & CEODec 15Option Exercise6.4522,000141,900845,513Dec 16 05:16 PM
Crowley John FChairman & CEODec 15Sale23.9122,000526,101823,513Dec 16 05:16 PM
Do HungChief Science OfficerDec 14Sale23.88111,1252,653,276409,682Dec 16 05:15 PM
Campbell Bradley LChief Operating OfficerDec 01Option Exercise2.5224,78362,453363,547Dec 02 06:39 PM
WHITMAN BURKE WDirectorDec 01Buy23.501,50035,25038,467Dec 03 06:27 PM
Campbell Bradley LChief Operating OfficerDec 01Sale22.7724,783564,192338,764Dec 02 06:39 PM
Crowley John FChairman & CEODec 01Sale22.777,500170,777823,513Dec 02 06:41 PM
Prout SamanthaPrincipal Accounting OfficerNov 04Option Exercise14.405,93185,37823,066Nov 06 05:57 PM
Prout SamanthaPrincipal Accounting OfficerNov 04Sale20.005,931118,62017,135Nov 06 05:57 PM
Campbell Bradley LChief Operating OfficerNov 02Option Exercise2.5224,78262,451363,546Nov 04 07:11 PM
Crowley John FChairman & CEONov 02Option Exercise5.9623,975142,891864,888Nov 04 07:24 PM
WHITMAN BURKE WDirectorNov 02Buy18.011,50027,01536,967Nov 04 07:25 PM
Campbell Bradley LChief Operating OfficerNov 02Sale17.8724,782442,792338,764Nov 04 07:11 PM
Crowley John FChairman & CEONov 02Sale17.8733,875605,272831,013Nov 04 07:24 PM
Do HungChief Science OfficerOct 09Option Exercise10.19193,7001,974,507714,507Oct 13 05:00 PM
Do HungChief Science OfficerOct 09Sale15.03193,7002,911,272520,807Oct 13 05:00 PM
Quimi DaphneChief Financial OfficerOct 02Option Exercise2.4511,00026,950218,179Oct 05 05:10 PM
Quimi DaphneChief Financial OfficerOct 01Option Exercise2.945,00014,700212,179Oct 05 05:10 PM
Crowley John FChairman & CEOOct 01Option Exercise5.9620,000119,200870,813Oct 05 05:11 PM
WHITMAN BURKE WDirectorOct 01Buy14.281,50021,41335,467Oct 05 05:12 PM
Crowley John FChairman & CEOOct 01Sale14.0229,900419,105840,913Oct 05 05:11 PM
Quimi DaphneChief Financial OfficerOct 01Sale14.025,00070,099207,179Oct 05 05:10 PM
Barth JayChief Medical OfficerSep 30Option Exercise2.294,0649,307167,268Oct 02 04:34 PM
Barth JayChief Medical OfficerSep 30Sale14.514,06458,951163,204Oct 02 04:34 PM
Campbell Bradley LChief Operating OfficerSep 28Option Exercise2.5224,78262,451363,546Sep 30 04:38 PM
Campbell Bradley LChief Operating OfficerSep 28Sale13.8924,782344,205338,764Sep 30 04:38 PM
Crowley John FChairman & CEOSep 01Option Exercise5.9620,000119,200880,713Sep 02 04:28 PM
WHITMAN BURKE WDirectorSep 01Buy14.621,50021,93033,967Sep 02 04:28 PM
Crowley John FChairman & CEOSep 01Sale14.1829,900423,850850,813Sep 02 04:28 PM
Barth JayChief Medical OfficerAug 31Option Exercise6.1028,750175,375191,954Sep 02 04:27 PM
Barth JayChief Medical OfficerAug 31Sale14.7428,750423,746163,204Sep 02 04:27 PM
Crowley John FChairman & CEOAug 17Option Exercise5.1320,000102,600880,713Aug 19 04:56 PM
Crowley John FChairman & CEOAug 17Sale14.8920,000297,814860,713Aug 19 04:56 PM
Prout SamanthaPrincipal Accounting OfficerAug 05Option Exercise10.041981,98817,333Aug 07 08:04 PM
Prout SamanthaPrincipal Accounting OfficerAug 05Sale15.051982,98017,135Aug 07 08:04 PM
Crowley John FChairman & CEOAug 03Option Exercise5.9620,000119,200900,368Aug 05 04:02 PM
Campbell Bradley LChief Operating OfficerAug 03Option Exercise6.0610,00060,600348,764Aug 05 04:03 PM
WHITMAN BURKE WDirectorAug 03Buy14.531,50021,79532,467Aug 05 04:05 PM
Campbell Bradley LChief Operating OfficerAug 03Sale14.7810,000147,779338,764Aug 05 04:03 PM
Crowley John FChairman & CEOAug 03Sale14.7839,655586,081860,713Aug 05 04:02 PM
Barth JayChief Medical OfficerJul 27Option Exercise6.1030,000183,000193,204Jul 29 09:41 PM
Barth JayChief Medical OfficerJul 27Sale15.0530,000451,377163,204Jul 29 09:41 PM
Rosenberg EllenChief Legal OfficerJul 16Option Exercise5.1630,000154,800225,169Jul 20 05:31 PM
Rosenberg EllenChief Legal OfficerJul 16Sale15.2630,000457,911195,169Jul 20 05:31 PM
Crowley John FChairman & CEOJul 15Option Exercise5.1320,000102,600900,368Jul 17 06:28 PM
Crowley John FChairman & CEOJul 15Sale15.5420,000310,848880,368Jul 17 06:28 PM
Barth JayChief Medical OfficerJul 10Option Exercise5.1328,843147,965192,047Jul 13 06:54 PM
Barth JayChief Medical OfficerJul 10Sale15.6528,843451,433163,204Jul 13 06:54 PM
Barth JayChief Medical OfficerJul 09Option Exercise10.3744,447460,867207,651Jul 13 06:54 PM
Barth JayChief Medical OfficerJul 09Sale15.9244,447707,494163,204Jul 13 06:54 PM
Campbell Bradley LChief Operating OfficerJul 08Option Exercise6.062,50015,150341,264Jul 09 06:47 PM
Barth JayChief Medical OfficerJul 08Option Exercise10.1764,110652,165227,314Jul 09 06:51 PM
Barth JayChief Medical OfficerJul 08Sale15.9264,1101,020,574163,204Jul 09 06:51 PM
Campbell Bradley LChief Operating OfficerJul 08Sale16.012,50040,025338,764Jul 09 06:47 PM
Barth JayChief Medical OfficerJul 07Option Exercise9.89178,9881,770,220342,192Jul 09 06:51 PM
Barth JayChief Medical OfficerJul 07Sale15.90178,9882,845,945163,204Jul 09 06:51 PM
Prout SamanthaPrincipal Accounting OfficerJul 02Option Exercise10.041981,9881,733Jul 06 07:50 PM
Prout SamanthaPrincipal Accounting OfficerJul 02Sale15.801983,12817,135Jul 06 07:50 PM
Campbell Bradley LChief Operating OfficerJul 01Option Exercise6.0612,50075,750351,264Jul 06 07:47 PM
Crowley John FChairman & CEOJul 01Option Exercise5.9620,000119,200920,023Jul 06 07:45 PM
Quimi DaphneChief Financial OfficerJul 01Option Exercise2.6219,87252,054214,051Jul 06 07:38 PM
WHITMAN BURKE WDirectorJul 01Buy15.201,50022,80030,967Jul 06 07:38 PM
Campbell Bradley LChief Operating OfficerJul 01Sale15.4712,500193,384338,764Jul 06 07:47 PM
Crowley John FChairman & CEOJul 01Sale15.4839,655613,859880,368Jul 06 07:45 PM
Quimi DaphneChief Financial OfficerJul 01Sale15.476,872106,326207,179Jul 06 07:38 PM
Barth JayChief Medical OfficerJun 29Option Exercise5.1330,000153,900193,204Jul 01 07:00 PM
Barth JayChief Medical OfficerJun 29Sale15.5130,000465,195163,204Jul 01 07:00 PM
Prout SamanthaPrincipal Accounting OfficerJun 19Option Exercise10.043,36633,79520,501Jun 23 06:47 PM
Prout SamanthaPrincipal Accounting OfficerJun 19Sale15.003,36650,49017,135Jun 23 06:47 PM
Barth JayChief Medical OfficerJun 17Sale13.471,90425,639163,204Jun 17 08:33 PM
Prout SamanthaPrincipal Accounting OfficerJun 16Sale12.952,93237,95917,135Jun 17 08:25 PM
Crowley John FChairman & CEOJun 15Option Exercise5.1320,000102,600920,186Jun 17 08:26 PM
Crowley John FChairman & CEOJun 15Sale10.8820,000217,610900,186Jun 17 08:26 PM
Campbell Bradley LChief Operating OfficerJun 02Option Exercise6.062,50015,150350,353Jun 03 09:10 PM
WHITMAN BURKE WDirectorJun 02Buy12.662,00025,31123,612Jun 03 09:06 PM
Campbell Bradley LChief Operating OfficerJun 02Sale13.012,50032,525347,853Jun 03 09:10 PM
RAAB MICHAELDirectorJun 01Option Exercise2.815,00014,05020,145Jun 03 09:09 PM
Campbell Bradley LChief Operating OfficerJun 01Option Exercise6.0610,00060,600365,355Jun 03 09:10 PM
Crowley John FChairman & CEOJun 01Sale12.669,755123,452900,186Jun 03 09:14 PM
Campbell Bradley LChief Operating OfficerJun 01Sale12.6617,502221,495347,853Jun 03 09:10 PM
RAAB MICHAELDirectorJun 01Sale12.655,00063,26115,145Jun 03 09:09 PM
Campbell Bradley LChief Operating OfficerMay 26Option Exercise6.062,50015,150357,855May 28 05:20 PM
Campbell Bradley LChief Operating OfficerMay 26Sale13.012,50032,525355,355May 28 05:20 PM
Crowley John FChairman & CEOMay 15Option Exercise5.1320,000102,600959,941May 19 07:52 PM
Crowley John FChairman & CEOMay 15Sale11.4420,000228,796939,941May 19 07:52 PM
Campbell Bradley LChief Operating OfficerMay 01Option Exercise6.0610,00060,600372,858May 05 05:46 PM
Campbell Bradley LChief Operating OfficerMay 01Sale11.3317,503198,239355,355May 05 05:46 PM
Crowley John FChairman & CEOMay 01Sale11.329,755110,469939,941May 05 05:45 PM
MCGLYNN MARGARET GDirectorApr 17Option Exercise2.8110,00028,10032,064Apr 20 04:57 PM